IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q3 FY26 results · Oct–Dec 2025
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹580.39 crore (up 10.9% from Q3 FY25) and net profit of ₹20.58 crore (up 0.2% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 580.39 | 523.30 | +10.9% | 567.53 | +2.3% |
| Other income | 5.29 | 4.07 | +30.0% | 6.88 | −23.1% |
| Total income | 585.68 | 527.37 | +11.1% | 574.41 | +2.0% |
| Profit before tax | 27.55 | 27.80 | −0.9% | 40.49 | −32.0% |
| Net profit for the period | 20.58 | 20.53 | +0.2% | 29.97 | −31.3% |
| EPS, basic (₹) | 0.70 | 3.50 | not comparable | 1.02 | −31.4% |
| Net margin (%) | 3.5 | 3.9 | 5.3 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 580.39 | 523.30 | +10.9% | 567.53 | +2.3% |
| Other income | 5.29 | 4.07 | +30.0% | 6.88 | −23.1% |
| Total income | 585.68 | 527.37 | +11.1% | 574.41 | +2.0% |
| Profit before tax | 27.55 | 27.82 | −1.0% | 40.52 | −32.0% |
| Net profit for the period | 20.58 | 20.55 | +0.1% | 30.00 | −31.4% |
| EPS, basic (₹) | 0.70 | 3.50 | not comparable | 1.02 | −31.4% |
| Net margin (%) | 3.5 | 3.9 | 5.3 |
Consolidated
- Filed with BSE
- 11 Feb 2026, 17:10 IST
- Board meeting
- 11 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Feb 2026, 17:10 IST
- Board meeting
- 11 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE